Shire buys US drugs rival for $32bn

Home › Shire buys US drugs rival for $32bn

UK pharmaceutical firm Shire reaches a $32bn (22bn) deal for US rival Baxalta to create rare-disease drugs giant.

27.11	Loyalty cards offer genuine savings, says watchdog
27.11	Aston Martin issues second profit warning in two months
27.11	Online slots gambling to be limited to 5 per spin
26.11	Black Friday shoppers warned to be wary of deals
26.11	Trump proves he is serious on tariffs - but it's not about trade
26.11	Sports service SPOTV adopts Zixi for affiliate delivery
26.11	'I want to get a job but I don't know how'
26.11	EQT to sell Melita to Goldman Sachs Alternatives
Consumer Goods and Services »

je.st